🇺🇸 FDA
Patent

US 11759482

Methods and compositions for treating skeletal muscular dystrophy

granted A61KA61K31/7105A61K35/34

Quick answer

US patent 11759482 (Methods and compositions for treating skeletal muscular dystrophy) held by Capricor, Inc. expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Capricor, Inc.
Grant date
Tue Sep 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/7105, A61K35/34, A61K9/0019, A61P